SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-046549
Filing Date
2018-07-23
Accepted
2018-07-23 17:09:34
Documents
4
Period of Report
2018-07-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-17614_18k.htm 8-K 20931
2 EX-99.1 a18-17614_1ex99d1.htm EX-99.1 10296
3 GRAPHIC g176141mmi001.jpg GRAPHIC 3759
4 GRAPHIC g176141mmi002.gif GRAPHIC 633
  Complete submission text file 0001104659-18-046549.txt   38729
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38129 | Film No.: 18965067
SIC: 2834 Pharmaceutical Preparations